FindTrial
Sign In

Evaluation of misoprostol use for cervical preparation in molar pregnancy

Effects of using misoprostol for cervical ripening in molar pregnancy, A Randomized Controlled Trial Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200216046519N1
Enrollment
75
Registered
2020-03-11
Start date
2018-03-21
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Molar Pregnancy.

Interventions

Intervention group: Pregnant mothers who received corticosteroid misoprostol at a dose of 400 microgram before suction.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant women with molar pregnancy who are candidates for termination of pregnancy

Exclusion criteria

Exclusion criteria: They are allergic to prostaglandins

Design outcomes

Primary

MeasureTime frame
Age of a small and independent variable - Gestational age of a small and independent variable - Parity of a small and independent variable - Uterine size of a small and independent variable - Bleeding during and after K. Quantitative and dependent variable drainage - Long-term variable and dependent variable of operation Quantitative and dependent variables of dilators. Timepoint: . Method of measurement: questionnaire.—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactyekta parsa

Shahid Beheshti University of Medical Sciences

yektaparsa@sbmu.ac.ir+98 21 2200 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026